HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Oliver Sartor Selected Research

Castration

11/2015Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
9/2015Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents.
9/2015The timing of radium-223 therapy in castration-resistant prostate cancer.
9/2015Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes.
8/2015A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer.
7/2015Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects.
11/2014Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
10/2014Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.
9/2014Taxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicity.
9/2014Prostate cancer: the best fit for enzalutamide in metastatic prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Oliver Sartor Research Topics

Disease

106Prostatic Neoplasms (Prostate Cancer)
11/2015 - 05/2002
30Neoplasms (Cancer)
04/2015 - 05/2002
13Neoplasm Metastasis (Metastasis)
07/2015 - 05/2004
8Disease Progression
03/2013 - 01/2004
6Pain (Aches)
10/2014 - 01/2004
4Adenocarcinoma
01/2013 - 03/2010
4Anemia
11/2012 - 05/2002
3Progressive Multifocal Leukoencephalopathy
12/2014 - 05/2009
3Neutropenia
11/2014 - 05/2002
3Drug Toxicity (Drug Safety)
11/2012 - 05/2009
3Atrophy
12/2005 - 10/2004
2Thrombocytopenia (Thrombopenia)
11/2014 - 05/2009
2Lymphoma (Lymphomas)
08/2014 - 03/2010
2Kidney Diseases (Kidney Disease)
12/2012 - 11/2012
2Breast Neoplasms (Breast Cancer)
03/2012 - 01/2010
2Diarrhea
05/2010 - 01/2004
1Peripheral Nervous System Diseases (PNS Diseases)
08/2015
1Dysgeusia (Parageusia)
08/2015
1Alopecia (Baldness)
08/2015
1Circulating Neoplastic Cells
05/2015
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2014
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2014
1Chromosome Aberrations (Chromosome Abnormalities)
04/2014
1Renal Cell Carcinoma (Grawitz Tumor)
12/2012
1Multiple Myeloma
11/2012
1Venous Thromboembolism
11/2012
1Myocardial Infarction
11/2012
1Stroke (Strokes)
11/2012

Drug/Important Bio-Agent (IBA)

22HormonesIBA
09/2014 - 05/2002
22Prostate-Specific Antigen (Semenogelase)IBA
11/2013 - 09/2002
21docetaxel (Taxotere)FDA Link
09/2015 - 02/2008
12Androgen Receptors (Androgen Receptor)IBA
09/2015 - 09/2002
7Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2015 - 02/2003
7Testosterone (Sustanon)FDA Link
01/2015 - 02/2003
64- acetoxy- 13- ((3- ((tert- butoxycarbonyl)amino)- 2- hydroxy- 3- phenylpropanoyl)oxy)- 1- hydroxy- 7,10- dimethoxy- 9- oxo- 5,20- epoxytax- 11- en- 2- yl benzoateFDA Link
08/2015 - 01/2010
6abirateroneIBA
05/2015 - 02/2011
6Prednisone (Sone)FDA LinkGeneric
12/2014 - 11/2009
5dutasteride (Avodart)FDA Link
08/2015 - 02/2009
3Messenger RNA (mRNA)IBA
05/2015 - 05/2005
3Leuprolide (Lupron)FDA LinkGeneric
01/2015 - 08/2003
3RadiopharmaceuticalsIBA
10/2014 - 05/2011
3Dexamethasone (Maxidex)FDA LinkGeneric
09/2014 - 05/2010
3Hemoglobins (Hemoglobin)IBA
11/2013 - 05/2005
3HematinicsIBA
11/2012 - 03/2010
3Mitoxantrone (Novantrone)FDA LinkGeneric
01/2011 - 01/2008
3SaposinsIBA
12/2005 - 11/2004
2zoledronic acid (zoledronate)FDA Link
11/2015 - 03/2006
2denosumabFDA Link
11/2015 - 07/2011
2DiphosphonatesIBA
11/2015 - 03/2006
2bicalutamide (Casodex)FDA LinkGeneric
08/2015 - 10/2009
2RadiumIBA
04/2015 - 12/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014 - 11/2012
2rituximab (Mabthera)FDA Link
12/2014 - 05/2009
2TaxoidsIBA
09/2014 - 06/2011
2Biological Markers (Surrogate Marker)IBA
05/2014 - 05/2009
2Alkaline PhosphataseIBA
11/2013 - 05/2005
2Dihydrotestosterone (Androstanolone)IBA
03/2013 - 10/2009
2ErythropoietinFDA Link
11/2012 - 03/2012
2Thalidomide (Thalomid)FDA Link
11/2012 - 03/2009
2sipuleucel-T (APC8015)FDA Link
07/2012 - 10/2011
2taxaneIBA
06/2011 - 01/2010
2Ketoconazole (Nizoral)FDA LinkGeneric
11/2009 - 10/2009
2PlatinumIBA
11/2009 - 01/2008
2SamariumIBA
02/2007 - 01/2004
2Phosphotransferases (Kinase)IBA
06/2005 - 11/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2005 - 05/2005
2prosaptideIBA
11/2004 - 10/2004
2Protein Kinases (Protein Kinase)IBA
11/2004 - 10/2004
2Estrogens (Estrogen)FDA Link
01/2004 - 02/2003
2Radioisotopes (Radionuclides)IBA
01/2004 - 05/2003
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2014
1Vincristine (Oncovin)FDA LinkGeneric
12/2014
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2014
1GlucocorticoidsIBA
09/2014
1cAC10-vcMMAEIBA
08/2014
1Carbon MonoxideIBA
04/2014
1GTP Phosphohydrolases (GTPases)IBA
04/2014
1Conditioned Culture MediaIBA
04/2014
1sunitinib (Sutent)FDA Link
01/2014
1methaneselenolIBA
11/2013
1MDV 3100IBA
11/2013
1familial Prostate cancerIBA
05/2013
1Tuberculin (PPD)IBA
03/2013
1Diethylstilbestrol (Stilbestrol)FDA Link
12/2012
1gadodiamide (Omniscan)FDA Link
12/2012
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
11/2012
1Glutamic Acid (Glutamate)FDA Link
11/2012
1Phenobarbital (Luminal)FDA Link
11/2012
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2012
1InterleukinsIBA
05/2012
1Interleukin-17 (Interleukin 27)IBA
05/2012

Therapy/Procedure

45Castration
11/2015 - 02/2003
23Drug Therapy (Chemotherapy)
09/2015 - 10/2004
7Prostatectomy (Retropubic Prostatectomy)
05/2013 - 12/2007
6Heterologous Transplantation (Xenotransplantation)
09/2014 - 12/2005
3Aftercare (After-Treatment)
09/2011 - 03/2008
2Brachytherapy
01/2013 - 07/2012
1Injections
11/2014
1Radiotherapy
01/2013
1Nephrectomy
12/2012